Mark Kazatsker

525 total citations
27 papers, 348 citations indexed

About

Mark Kazatsker is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Mark Kazatsker has authored 27 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Mark Kazatsker's work include Cardiac pacing and defibrillation studies (9 papers), Heart Failure Treatment and Management (8 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Mark Kazatsker is often cited by papers focused on Cardiac pacing and defibrillation studies (9 papers), Heart Failure Treatment and Management (8 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Mark Kazatsker collaborates with scholars based in Israel, United States and Canada. Mark Kazatsker's co-authors include Avraham Shotan, Simcha Meisel, David S. Blondheim, Michael Shochat, Michael Glikson, Yoseph Rozenman, Aaron Frimerman, Iris Dahan, Mahmoud Suleiman and Avi Sabbag and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Mark Kazatsker

24 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kazatsker Israel 11 300 93 53 22 19 27 348
Beata Uziębło‐Życzkowska Poland 11 248 0.8× 74 0.8× 65 1.2× 20 0.9× 16 0.8× 54 346
Haotian Gu United Kingdom 12 258 0.9× 50 0.5× 63 1.2× 24 1.1× 7 0.4× 34 351
Federica Guidetti Sweden 8 168 0.6× 51 0.5× 24 0.5× 20 0.9× 16 0.8× 17 233
Karin Rybak Germany 9 331 1.1× 76 0.8× 29 0.5× 15 0.7× 23 1.2× 29 378
N. Mehta United Kingdom 9 301 1.0× 119 1.3× 119 2.2× 23 1.0× 79 4.2× 28 362
Satoshi Jissho Japan 11 239 0.8× 92 1.0× 100 1.9× 28 1.3× 13 0.7× 17 338
Jan Knierim Germany 11 193 0.6× 156 1.7× 42 0.8× 27 1.2× 12 0.6× 40 298
Jaimie Manlucu Canada 12 462 1.5× 77 0.8× 25 0.5× 15 0.7× 7 0.4× 48 520
Leonida Compostella Italy 10 186 0.6× 68 0.7× 24 0.5× 23 1.0× 24 1.3× 25 274
Linda Huffer United States 6 302 1.0× 53 0.6× 47 0.9× 19 0.9× 13 0.7× 8 367

Countries citing papers authored by Mark Kazatsker

Since Specialization
Citations

This map shows the geographic impact of Mark Kazatsker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kazatsker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kazatsker more than expected).

Fields of papers citing papers by Mark Kazatsker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kazatsker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kazatsker. The network helps show where Mark Kazatsker may publish in the future.

Co-authorship network of co-authors of Mark Kazatsker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kazatsker. A scholar is included among the top collaborators of Mark Kazatsker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kazatsker. Mark Kazatsker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Margolis, Gilad, et al.. (2024). In‐Hospital Outcomes of Ventricular Tachycardia Catheter Ablation in the Presence of Intra‐Cardiac Thrombus. Pacing and Clinical Electrophysiology. 47(11). 1433–1440.
3.
Margolis, Gilad, et al.. (2024). Atrial Fibrillation Catheter Ablation among Cancer Patients: Utilization Trends and In-Hospital Outcomes. Journal of Clinical Medicine. 13(5). 1318–1318. 4 indexed citations
4.
Margolis, Gilad, Ofer Kobo, Gabby Elbaz‐Greener, et al.. (2023). Single‐ Versus Dual‐Chamber Implantable Cardioverter‐Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States. Journal of the American Heart Association. 12(15). e029126–e029126. 1 indexed citations
5.
Topaz, Moris, Ehud Chorin, Arie Lorin Schwartz, et al.. (2023). Regional Antibiotic Delivery for Implanted Cardiovascular Electronic Device Infections. Journal of the American College of Cardiology. 81(2). 119–133. 15 indexed citations
6.
Fudim, Marat, Andrew P. Ambrosy, Mark Kazatsker, et al.. (2020). The Degree of the Predischarge Pulmonary Congestion in Patients Hospitalized for Worsening Heart Failure Predicts Readmission and Mortality. Cardiology. 146(1). 49–59. 3 indexed citations
7.
Shochat, Michael, Marat Fudim, Avraham Shotan, et al.. (2018). Prediction of Readmissions and Mortality in Patients with Heart Failure: Lessons from the IMPEDANCE-HF Extended Trial. ESC Heart Failure. 5(5). 788–799. 22 indexed citations
8.
Blondheim, David S., et al.. (2018). Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non–ST-elevation Myocardial Infarction. The American Journal of Cardiology. 121(12). 1449–1455. 20 indexed citations
9.
Shochat, Michael, Avraham Shotan, Iris Dahan, et al.. (2016). NON-INVASIVE LUNG IMPEDANCE-GUIDED PREEMPTIVE TREATMENT IN CHRONIC HEART FAILURE PATIENTS: A RANDOMIZED CONTROLLED TRIAL (IMPEDANCE-HF TRIAL). Journal of the American College of Cardiology. 67(13). 1278–1278. 2 indexed citations
10.
Shochat, Michael, Avraham Shotan, David S. Blondheim, et al.. (2016). Non-Invasive Lung IMPEDANCE-Guided Preemptive Treatment in Chronic Heart Failure Patients: A Randomized Controlled Trial (IMPEDANCE-HF Trial). Journal of Cardiac Failure. 22(9). 713–722. 63 indexed citations
11.
Sabbag, Avi, Mahmoud Suleiman, Avishag Laish‐Farkash, et al.. (2015). Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry. Heart Rhythm. 12(12). 2426–2433. 81 indexed citations
12.
Shochat, Michael, Avraham Shotan, David S. Blondheim, et al.. (2014). Derivation of baseline lung impedance in chronic heart failure patients: use for monitoring pulmonary congestion and predicting admissions for decompensation. Journal of Clinical Monitoring and Computing. 29(3). 341–349. 19 indexed citations
13.
Amit, Guy, Yuval Konstantino, David Luria, et al.. (2014). Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. EP Europace. 16(8). 1175–1180. 26 indexed citations
14.
Shochat, Michael, Avraham Shotan, David S. Blondheim, et al.. (2012). Usefulness of Lung Impedance-Guided Pre-Emptive Therapy to Prevent Pulmonary Edema During ST-Elevation Myocardial Infarction and to Improve Long-Term Outcomes. The American Journal of Cardiology. 110(2). 190–196. 13 indexed citations
15.
Shochat, Michael, Avraham Shotan, Mark Kazatsker, et al.. (2011). LUNG IMPEDANCE MONITORING IN THE OUTPATIENT CLINIC PREDICT HOSPITALIZATIONS OF PATIENTS WITH DECOMPENSATED HEART FAILURE AND ENABLES EARLY THERAPY TO PREVENT HOSPITALIZATIONS. Journal of the American College of Cardiology. 57(14). E1259–E1259. 1 indexed citations
16.
Shochat, Michael, Avraham Shotan, David S. Blondheim, et al.. (2011). A novel radiological score to assess lung fluid content during evolving acute heart failure in the course of acute myocardial infarction. Acute Cardiac Care. 13(2). 81–86. 16 indexed citations
17.
Shochat, Michael, et al.. (2011). IMPORTANCE LUNG IMPEDANCE-GUIDED TREATMENT OF THE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION FOR PREVENTING ACUTE HEART FAILURE AND REDUCING LONG-TERM MORTALITY. Journal of the American College of Cardiology. 57(14). E1072–E1072.
18.
Meisel, Simcha, David S. Blondheim, Michael Shochat, et al.. (2008). Transient ST-elevation myocardial infarction: Clinical course with intense medical therapy and early invasive approach, and comparison with persistent ST-elevation myocardial infarction. American Heart Journal. 155(5). 848–854. 22 indexed citations
19.
Blondheim, David S., Mark Kazatsker, Zvi Friedman, et al.. (2007). Effect of Medical Therapy for Heart Failure on Segmental Myocardial Function in Patients With Ischemic Cardiomyopathy. The American Journal of Cardiology. 99(12). 1741–1744. 5 indexed citations
20.
Kazatsker, Mark, et al.. (2002). Two Pacemakers in One Patient: A Stimulating Case. Journal of Cardiovascular Electrophysiology. 13(5). 522–522. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beata Uziębło‐Życzkowska Breakdown of academic impact, for papers by Haotian Gu Breakdown of academic impact, for papers by Federica Guidetti Breakdown of academic impact, for papers by Karin Rybak Breakdown of academic impact, for papers by N. Mehta Breakdown of academic impact, for papers by Satoshi Jissho Breakdown of academic impact, for papers by Jan Knierim Breakdown of academic impact, for papers by Jaimie Manlucu Breakdown of academic impact, for papers by Leonida Compostella Breakdown of academic impact, for papers by Linda Huffer
Rankless by CCL
2026